2024 Reassignment of Low-Income Subsidy Beneficiaries in Prescription Drug Plans September 2023 Memos / By Nermine Farahat Relevant to: PDPs
2024 Reassignment of Low-Income Subsidy Beneficiaries in Non-Renewing Medicare Advantage Plans and Medicare Advantage Plans Reducing their Service Areas September 2023 Memos / By Nermine Farahat Relevant to: MAOs
2023 Medicare Advantage Organization and Prescription Drug Plan Fraud, Waste, and Abuse Training Postponed Until 2024 September 2023 Memos / By Nermine Farahat Relevant to: MAOs, PDPs
Corrections to the Year of Service (YOS) 2021 Polypharmacy: Use of Multiple Central-Nervous System – Active Medications in Older September 2023 Memos / By Nermine Farahat Relevant to: PDPs, PACE, Cost, MA-PD
Medicare Advantage/Prescription Drug System (MARx) October 2023 Payment – INFORMATION September 2023 Memos / By Nermine Farahat Relevant to: PDPs, MAOs, PACE, Cost
Non-Renewal and Service Area Reduction Guidance and EnrolleeNotification Models September 2023 Memos / By Nermine Farahat Relevant to: MAOs, PDPs, Cost, MMPs
Corrected Contract Year 2024 Translated Model Materials Requirements and Language Data Analysis September 2023 Memos / By Nermine Farahat Relevant to: MA, PDPs
Results of the 2023 Part C and D Reporting Requirements Data Validation September 2023 Memos / By Nermine Farahat Relevant to: MMPs, PDPs, MAOs
Retail Pharmacy Network Access and Preferred Cost-Sharing Pharmacy Access Analysis Results for Q3 CY 2023 September 2023 Memos / By Nermine Farahat Relevant to: MPDP